Xiao‐ping Wan - Gynecology

Author Information

Dr. Xiao-ping Wan is a distinguished researcher affiliated with the Department of Gynecology at Shanghai First Maternity and Infant Hospital, Tongji University School of Medicine, Shanghai, PR China. Her research primarily focuses on gynecological oncology, with particular emphasis on endometrial cancer and its associated immunological aspects.

Research Contributions

Dr. Xiao-ping Wan has made significant contributions to the field of gynecological oncology. Her work includes studies on the immunomodulatory-related prognostic biomarkers in various cancers, exosome-contained APOH in antiphospholipid syndrome, and the interplay between commensal bacteria and fibrin degradation in endometrial cancer. She has also explored the immune landscape in tumor microenvironments and the role of estrogen-ERα signaling in endometrial cancer cells. Her research has provided valuable insights into the molecular mechanisms underlying these diseases and has implications for the development of novel therapeutic strategies.

Aliases

Xiaoping Wan, Xiao-ping Wan, Xiao Ping Wan, Xiao–ping Wan, X. P. Wan

Publication and Citation Metrics

Metric	Value
Total Citation Count	3717
H-Index	38
Total Number of Papers	131

Publications:

ISYNA1: An Immunomodulatory-Related Prognostic Biomarker in Colon Adenocarcinoma and Pan-Cancer

DOI: 10.3389/fcell.2022.792564

Year: 2022

Exosome-Contained APOH Associated With Antiphospholipid Syndrome

DOI: 10.3389/fimmu.2021.604222

Year: 2021

Integrated Analysis of Microbiome and Transcriptome Data Reveals the Interplay Between Commensal Bacteria and Fibrin Degradation in Endometrial Cancer

DOI: 10.3389/fcimb.2021.748558

Year: 2021

Single cell transcriptome analysis of decidua macrophages in normal and recurrent spontaneous abortion patients

DOI: 10.1101/2021.03.23.436615

Year: 2021

Phenotyping of immune and endometrial epithelial cells in endometrial carcinomas revealed by single-cell RNA sequencing

DOI: 10.18632/aging.202288

Year: 2021

Estrogen-ERα signaling and DNA hypomethylation co-regulate expression of stem cell protein PIWIL1 in ERα-positive endometrial cancer cells

DOI: 10.1186/s12964-020-00563-4

Year: 2020

Identification of Interleukin-9 Producing Immune Cells in Endometrial Carcinoma and Establishment of a Prognostic Nomogram

DOI: 10.3389/fimmu.2020.544248

Year: 2020

POLE Mutation Characteristics in a Chinese Cohort with Endometrial Carcinoma

DOI: 10.2147/OTT.S258642

Year: 2020

Prognostic significance of immune landscape in tumour microenvironment of endometrial cancer

DOI: 10.1111/jcmm.15408

Year: 2020

A high-throughput small molecule screen identifies farrerol as a potentiator of CRISPR/Cas9-mediated genome editing

DOI: 10.7554/eLife.56008

Year: 2020

How Do Antigens Affect Gynecological Health?

What Issues Can Sex Therapists Help With?

How Does Metabolic Rate Affect Women's Health?

What are Common Gynecological Risk Factors?

What is the Link Between Metabolic Health and PCOS?

Does Cervarix Protect Against All HPV Types?

How is Severity Classified?

Is Epocrates user-friendly?

What are the Causes of PCOS?

How Do They Collaborate with Other Specialists?

Partnered Content Networks

Relevant Topics